Clinical Observation Of Baduanjn For Angina Pectoris,metabolic Equivalent And Quality Of Life Of Coronary Heart Disease Atable Angina Pectoris With Type 2 Diabetic Patients

Research purposes: based on the conventional drugs combined baduanjin for stable angina patients exercise tolerance of patients with type 2 diabetes,heart attacks,the quality of life status of observation,and compared with the conventional treatment group,and then evaluate the baduanjin in improving cardiac function,improve exercise tolerance,relieve angina and improve life quality of curative effect.Methods: according to the design requirements of randomized clinical trials,patients who met the inclusion criteria were divided into two groups.The control group: 30 patients with a sample size were given routine treatment(coronary heart disease secondary prevention routine drugs + hypoglycemic drugs).The experimental group included 30 patients,who were given conventional treatment + ba duan jin exercise prescription(exercise prescription should be formulated according to the patient's condition).The duration of the experiment was 3 months,and the efficacy indicators were blood glucose level,exercise tolerance,angina attack,and quality of life score(sf-36 scale).Results: 1.The baseline data of gender,age,course of disease,drug use,blood glucose and lipids in the two groups were analyzed,and the P values were all greater than 0.05,indicating that there was no significant difference between the two groups in baseline data,which was comparable.2.Analysis of clinical efficacy indicators1)the angina attack after treatment in both groups was significantly improved compared with that before treatment(P<0.05).Compared with the control group,the relief effect of angina in the experimental group was more obvious,and there was a significant difference between the two groups(P<0.05).2)FPG,2h PG and Hb A1 C in both groups were improved after treatment(P < 0.05),and the experimental group was significantly better than the control group(P < 0.05).3)the metabolic equivalent of the two groups of patients after treatment was improvedcompared with that before treatment(P < 0.05),and the experimental group was superior to the control group(P < 0.05).4)sf-36 scale.According to the comparison between groups,GH and PCS dimensions had statistical differences before intervention,suggesting that the sample size of this experiment should be further expanded.After intervention,there were statistical differences in PF,RP,GH,MH,PCS and MCS dimensions between the experimental group and the control group,while there were no statistical differences in RE and HT dimensions between the experimental group and the control group.According to the intra-group comparison,the scores of PF,BP,GH,SF,HT and MCS before and after the intervention in the test group were statistically significant(P < 0.05),while the scores of the control group were not statistically significant in the corresponding dimensions.Conclusions: 1.Baduanjin is safe and effective in the rehabilitation of patients with stable angina pectoris and diabetes mellitus.2.Baduanjin can improve clinical symptoms and indicators such as angina attack,blood glucose,and metabolic equivalent.3.Baduanjin can improve the quality of life of patients with stable angina pectoris complicated by coronary heart disease.For individual dimensions of sf-36 scale,such as the impact of emotional changes on daily work and life,and health self-evaluation,patients may need to adhere to baduanjin exercise for a long time to gradually show the effect.